A potential role for fat tissue as an HIV reservoir and source of chronic inflammation

September 24, 2015, Public Library of Science
CD4 staining among adipose tissue demonstrating that the main target of HIV, i.e. CD4 T cells, is indeed detectable in adipose tissue. Credit: CC-BY Damouche et al.

Viral persistence and chronic inflammation are two key features of HIV-positive patients on antiretroviral therapy (ART). A study published on September 24th in PLOS Pathogens reports results from macaques and humans that suggest an important role for adipose (fat) tissue as an HIV reservoir with inflammatory potential.

The establishment and persistence of low-grade inflammation in HIV-positive individuals on ART are not well understood. Given that (which makes up between 15 and 20% of the body weight in healthy people) is a source of inflammation in obese individuals, Christine Bourgeois and Olivier Lambotte, from the University Paris SUD, France, and colleagues, decided to investigate a possible role of the adipose tissue in humans infected with HIV and in macaques infected with simian immunodeficiency virus (SIV, an HIV relative that causes AIDS-like disease in some non-human primates).

They found that SIV infection in is associated with changes in the composition of the adipose tissue: Fat tissue from infected animals has higher densities of both adipocytes (fat storage ) and a mix of differentiated and undifferentiated cells called stromal vascular fraction or SVF that contains a large proportion of immune cells.

Moreover, these immune cells (CD4+ T cells, CD8+ T cells, and macrophages) show enhanced immune activation and/or inflammatory profiles compared with non-infected animals. The researchers were also able to detect SIV DNA and RNA in the combined total SVF as well as in isolated adipose tissue macrophages and CD4+ T cells.

They observed similar results in ART-controlled, HIV-infected patients who had undergone elective abdominal surgery: their SVF samples are positive for HIV DNA, and the researchers could show the presence of infected and virus-producing cells within the patients' adipose tissue and more specifically among adipose CD4+ T cells.

The researchers conclude that they "identified adipose tissue as a crucial cofactor in both viral persistence and chronic immune activation/inflammation during HIV infection", and propose that "modulating adipose tissue may constitute a valuable means of limiting both viral persistence and in ART-receiving HIV-infected patients".

Explore further: Immune cells proposed as HIV hideout don't last in primate model

More information: Damouche A, Lazure T, Avettand-Fènoël V, Huot N, Dejucq-Rainsford N, Satie A-P, et al. (2015) Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection. PLoS Pathog 11(9): e1005153. DOI: 10.1371/journal.ppat.1005153

Related Stories

Immune cells proposed as HIV hideout don't last in primate model

October 31, 2014
Where does HIV hide? Antiretroviral drugs can usually control the virus, but can't completely eliminate it. So any strategy to eradicate HIV from the body has to take into account not only the main group of immune cells the ...

HIV particles do not cause AIDS, our own immune cells do

August 27, 2015
Researchers from the Gladstone Institutes have revealed that HIV does not cause AIDS by the virus's direct effect on the host's immune cells, but rather through the cells' lethal influence on one another.

Stem cell transplant does not cure SHIV/AIDS after irradiation of infected rhesus macaques

September 25, 2014
A study published on September 25th in PLOS Pathogens reports a new primate model to test treatments that might cure HIV/AIDS and suggests answers to questions raised by the "Berlin patient", the only human thought to have ...

Lung microbiome similar with/without HIV

August 26, 2015
(HealthDay)—Lung microbiomes are similar in patients with and without HIV, although oral microbiomes do differ significantly, according to a study published online Aug. 6 in the American Journal of Respiratory and Critical ...

When fat is the solution: Using adipose cells to attenuate chagasic cardiomyopathy

August 6, 2015
Rio de Janeiro -It could be a plot for a vampire story: In the middle of the night, blood-sucking creatures feed on peoples' faces and spread a deadly disease to the hearts of millions, who are then fated to endure a painful ...

Review: inflammation's role in obesity-colorectal cancer link

September 13, 2012
(HealthDay)—A new review summarizes the ways in which inflammation and altered metabolism are associated with colorectal cancer in obese individuals; the review was published online Sept. 3 in Obesity Reviews.

Recommended for you

Long-acting injectable implant shows promise for HIV treatment and prevention

October 9, 2018
A persistent challenge in HIV/AIDS treatment and prevention is medication adherence – getting patients to take their medication as required to get the best results.

Scientists develop rapid test for diagnosing tuberculosis in people with HIV

October 8, 2018
An international team that includes Rutgers scientists has made significant progress in developing a urine diagnostic test that can quickly, easily and inexpensively identify tuberculosis infection in people also infected ...

Researchers uncover new role of TIP60 protein in controlling tumour formation

October 8, 2018
Scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have discovered a new molecular pathway that controls colorectal cancer development, and their exciting ...

Combination therapy targets latent reservoir of HIV

October 3, 2018
With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus (HIV) remains a major global epidemic. Existing antiretroviral drugs do not cure ...

Anti-integrin therapy effect on intestinal immune system in HIV-infected patients

October 3, 2018
In a study published today in Science Translational Medicine, Mount Sinai researchers describe for the first time a mechanism that may shrink collections of immune cells in the gastrointestinal (GI) tract, called lymphoid ...

No 'reservoir': Detectable HIV-1 in treated human liver cells found to be inert

October 1, 2018
In a proof-of-principle study, researchers at Johns Hopkins report that a certain liver immune cell called a macrophage contains only defective or inert HIV-1 copies, and aren't likely to restart infection on their own in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.